Picture of Vicplas International logo

569 — Vicplas International Share Price

0.000.00%
sg flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapNeutral

Momentum

Relative Strength (%)
1m+11.1%
3m
6m
1yr
Volume Change (%)
10d/3m
Price vs... (%)
52w High-25.76%
50d MA
200d MA

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Financial Summary

Year End 31st JulUnit201720182019202020212022E2023ECAGR / Avg
Total RevenueSG$m63.7170.2480.1788.85113.94n/an/a8.41%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%-43.81+14.1+14.72-12.59+157.06n/an/an/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Jul 202231st Jul 2023
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2022 / 2023

Blurred out image of Vicplas International EPS forecast chart

Profile Summary

VicPlas International Ltd is a Singapore-based investment holding company. The Company, through its subsidiaries, engages in research, design, development and manufacture of medical devices. It is also engaged in the manufacture, trading and distribution of piping systems for pipes and pipe fittings across diverse industries, including waste and potable water systems for residential homes, schools, commercial and industrial buildings; underground electrical and internal building wire piping systems, and data and signal line piping systems for telecommunications companies. It operates in two segments: medical devices, and pipes and pipe fittings. The Company operates in Singapore, Malaysia and China. Its subsidiaries include Vicplas Holdings Pte Ltd, Rimplas Industries Sdn. Bhd., Forefront Medical Investment Pte Ltd., Forefront (Xiamen) Medical Devices Co. Ltd and Forefront Medical Technology (Jiangsu) Co., Ltd.

Directors

Last Annual
July 31st, 2021
Last Interim
July 31st, 2021
Incorporated
October 30th, 1998
Public Since
April 22nd, 1999
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
sg flag iconSingapore Exchange Securities Trading Ltd
Shares in Issue
511,076,699
Blurred out image of a map
Address
35 Joo Koon Circle, 629110
Web
http://www.vicplas.com
Phone
+65 62623888
Auditors
Deloitte & Touche LLP

569 Share Price Performance

Similar to 569

Picture of Biolidics logo

Biolidics

sg flag iconSingapore Exchange Securities Trading Ltd

Picture of Medtecs International Ltd logo

Medtecs International Ltd

sg flag iconSingapore Exchange Securities Trading Ltd

Picture of QT Vascular logo

QT Vascular

sg flag iconSingapore Exchange Securities Trading Ltd

Picture of Riverstone Holdings logo

Riverstone Holdings

sg flag iconSingapore Exchange Securities Trading Ltd

Top Glove Bhd

sg flag iconSingapore Exchange Securities Trading Ltd

FAQ

Or unlock with your email

Or unlock with your email